$HBAN

Huntington Bancshares Incorporated (NASDAQ:HBAN) earnings in focus as analysts weigh growth driven by acquisitions against upcoming EPS data

Huntington Bancshares (HBAN) shares closed up 0.6% at $18.27 ahead of its Thursday earnings report. The quarter is its first full period after acquiring Cadence on Feb. 1. Preliminary estimates cite EPS of 36 to 39 cents and revenue of $2.80 to $2.84B, with Jefferies reiterating a $19 hold target.

Original reporting
Published Jul 22, 2026, 8:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 11:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntington Bancshares Incorporated (NASDAQ:HBAN) earnings in focus as analysts weigh growth driven by acquisitions against upcoming EPS data — source image
Decision brief

The 30-second read

$HBANNeutralMed
01

Why it matters

The key decision point is Thursday’s earnings and call, where investors will update estimates for costs, margin sustainability, and synergy timing after the Cadence conversion.

02

Market read

Earnings timing and integration cost/margin uncertainty create a near-term catalyst for HBAN estimate revisions and positioning.

03

What to watch

The article emphasizes diluted share growth (up 28.3%) and pre-tax integration items ($271M), but does not quantify how much of the EPS range is driven by one-time items versus sustainable operating performance.

Relevance 6/10Novelty 6/10Timing: Ahead of Thursday’s earnings release and 9 a.m. EDT call.

Background

Huntington completed its Cadence acquisition on Feb. 1 and is now entering its first full reporting period, with investors focused on integration progress and synergy realization.

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

Huntington’s first full quarter after its Cadence acquisition is set to be assessed, with EPS and revenue ranges and integration cost details discussed.

Expected impact

Moderate two-sided reaction risk around the earnings release, with upside if margin and synergy timing look better than implied and downside if costs or deposit pricing pressure persist.

Evidence & confidence

The article provides concrete Q1 reported figures (EPS 37 cents, NIM 3.24%, significant pre-tax items $271M) and frames the upcoming catalyst as Thursday’s results and call, but it does not provide the actual Q2 print or new guidance beyond ranges and an earlier analyst downgrade.

Market effects

Read-across for regional banks on how deposit pricing and integration costs affect net interest margin and EPS post-M&A.

Potential sentiment spillover to other US regional banks as investors compare NIM and deposit-cost dynamics.

Limited direct global impact; primarily a US financials earnings catalyst.

Counterpoint

The reported NIM improvement (3.24% vs 3.15% prior quarter) and loan/deposit balance contributions from Cadence and Veritex could offset integration costs more than the market expects.

Key entities

  • Huntington Bancshares Incorporated

    US regional bank facing an earnings catalyst tied to its Cadence acquisition integration and deal-driven growth expectations.

  • Cadence

    Acquired entity whose conversion and contribution to loan and deposit balances are central to Huntington’s post-deal performance narrative.

  • Jefferies Financial Group

    Issued a July 6 downgrade to hold on Huntington, citing an M&A-related discount and uncertainty around integration and margin prospects.

Related articles

$HBANMed

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.

$HBANMed

HUNTINGTON BANCSHARES INC /MD/ (HBAN): Results of Operations and Financial Condition

HUNTINGTON BANCSHARES INC /MD/ (HBAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 hban20260630_8kex992.htm EX-99.2 Document Exhibit 99.2 HUNTINGTON BANCSHARES INCORPORATED Quarterly Financial Supplement June 30, 2026 Table of Contents Quarterly Key Statistics 1 Year-to-Date Key Statistics 2 Consolidated Balance Sheets 4 Loans and Leases Composition 5

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.